{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "37000-518",
      "generic_name": "Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide, and Doxylamine Succinate",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks NyQuil Severe Cold and Flu",
      "brand_name_suffix": "Cold and Flu",
      "active_ingredients": [
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "10 mg/1"
        },
        {
          "name": "DOXYLAMINE SUCCINATE",
          "strength": "6.25 mg/1"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "5 mg/1"
        },
        {
          "name": "ACETAMINOPHEN",
          "strength": "325 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "37000-518-02",
          "description": "2 CAPSULE, LIQUID FILLED in 1 POUCH (37000-518-02)",
          "marketing_start_date": "20210101",
          "sample": false
        },
        {
          "package_ndc": "37000-518-08",
          "description": "1 BLISTER PACK in 1 CARTON (37000-518-08)  / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
          "marketing_start_date": "20190701",
          "sample": false
        },
        {
          "package_ndc": "37000-518-24",
          "description": "2 BLISTER PACK in 1 CARTON (37000-518-24)  / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK",
          "marketing_start_date": "20180710",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "CAPSULE, LIQUID FILLED",
      "spl_id": "5d1906f1-582a-c444-e063-6394a90af570",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20180710",
      "product_id": "37000-518_5d1906f1-582a-c444-e063-6394a90af570",
      "application_number": "M012",
      "brand_name_base": "Vicks NyQuil Severe",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Antihistamine [EPC]",
        "Histamine Receptor Antagonists [MoA]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}